X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs PIRAMAL ENTERPRISES - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD PIRAMAL ENTERPRISES ORCHID PHARMA LTD/
PIRAMAL ENTERPRISES
 
P/E (TTM) x -0.2 9.2 - View Chart
P/BV x 0.1 1.7 6.7% View Chart
Dividend Yield % 0.0 1.0 -  

Financials

 ORCHID PHARMA LTD   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
PIRAMAL ENTERPRISES
Mar-18
ORCHID PHARMA LTD/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs1943,083 6.3%   
Low Rs351,902 1.8%   
Sales per share (Unadj.) Rs276.5589.7 46.9%  
Earnings per share (Unadj.) Rs-79.2284.0 -27.9%  
Cash flow per share (Unadj.) Rs-43.5310.5 -14.0%  
Dividends per share (Unadj.) Rs025.00 0.0%  
Dividend yield (eoy) %01.0 0.0%  
Book value per share (Unadj.) Rs53.91,467.0 3.7%  
Shares outstanding (eoy) m70.45180.27 39.1%   
Bonus/Rights/Conversions ESOPIS-  
Price / Sales ratio x0.44.2 9.8%   
Avg P/E ratio x-1.48.8 -16.5%  
P/CF ratio (eoy) x-2.68.0 -32.8%  
Price / Book Value ratio x2.11.7 124.9%  
Dividend payout %08.8 0.0%   
Avg Mkt Cap Rs m8,067449,332 1.8%   
No. of employees `0002.86.8 40.9%   
Total wages/salary Rs m2,52719,881 12.7%   
Avg. sales/employee Rs Th6,956.115,535.6 44.8%   
Avg. wages/employee Rs Th902.52,905.4 31.1%   
Avg. net profit/employee Rs Th-1,993.07,482.5 -26.6%   
INCOME DATA
Net Sales Rs m19,477106,310 18.3%  
Other income Rs m4072,595 15.7%   
Total revenues Rs m19,884108,906 18.3%   
Gross profit Rs m1,10351,599 2.1%  
Depreciation Rs m2,5194,773 52.8%   
Interest Rs m5,22729,783 17.5%   
Profit before tax Rs m-6,23619,638 -31.8%   
Minority Interest Rs m202,801 0.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-125-28,764 0.4%   
Profit after tax Rs m-5,58051,203 -10.9%  
Gross profit margin %5.748.5 11.7%  
Effective tax rate %2.0-146.5 -1.4%   
Net profit margin %-28.748.2 -59.5%  
BALANCE SHEET DATA
Current assets Rs m11,014118,154 9.3%   
Current liabilities Rs m32,060462,260 6.9%   
Net working cap to sales %-108.1-323.7 33.4%  
Current ratio x0.30.3 134.4%  
Inventory Days Days9527 357.0%  
Debtors Days Days3447 72.1%  
Net fixed assets Rs m29,440113,727 25.9%   
Share capital Rs m705361 195.4%   
"Free" reserves Rs m2,043264,093 0.8%   
Net worth Rs m3,800264,454 1.4%   
Long term debt Rs m9,018242,206 3.7%   
Total assets Rs m46,510726,834 6.4%  
Interest coverage x-0.21.7 -11.6%   
Debt to equity ratio x2.40.9 259.1%  
Sales to assets ratio x0.40.1 286.3%   
Return on assets %-0.811.1 -6.8%  
Return on equity %-146.919.4 -758.5%  
Return on capital %-3.710.3 -36.2%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Exports (fob) Rs m7,378NA-   
Imports (cif) Rs m4,406NA-   
Fx inflow Rs m7,51315,110 49.7%   
Fx outflow Rs m5,6494,298 131.4%   
Net fx Rs m1,86510,813 17.2%   
CASH FLOW
From Operations Rs m1,682-159,666 -1.1%  
From Investments Rs m-9,860-17,677 55.8%  
From Financial Activity Rs m6,644186,503 3.6%  
Net Cashflow Rs m-1,5359,364 -16.4%  

Share Holding

Indian Promoters % 32.3 52.9 61.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 4.0 115.0%  
FIIs % 3.3 26.6 12.4%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 16.5 335.2%  
Shareholders   84,811 93,274 90.9%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   PFIZER  GSK PHARMA  PANACEA BIOTECH  DR. REDDYS LAB  ABBOTT INDIA  

Compare ORCHID PHARMA LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Share Markets Open Flat; Rupee Hits 70-Mark Again(09:30 am)

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.5% while the Hang Seng is flat.

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY19); Net Profit Up 21.8% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 21.8% YoY). Sales on the other hand came in at Rs 35 bn (up 22.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY19); Net Profit Up 59.3% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 59.3% YoY). Sales on the other hand came in at Rs 31 bn (up 24.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY19); Net Profit Down 152.5% (Quarterly Result Update)

Aug 1, 2018 | Updated on Aug 1, 2018

For the quarter ended June 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 1 bn (down 152.5% YoY). Sales on the other hand came in at Rs 29 bn (up 28.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

My Master Series on How to Trade Election 2019(Profit Hunter)

Apr 16, 2019

For 30 years he has watched how elections impact the markets, and practiced how to profit from it. Now he is here...telling you everything. Read on...

Election Series: Follow the World's Biggest Traders To See Where the Money Flows(The 5 Minute Wrapup)

Apr 17, 2019

20% of all the traders bring in 80% of the money. Watch these 20% and you get a working idea of which way the wind is blowing.

A Letter to You from India's No. 1 Trader(The 5 Minute Wrapup)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Apr 25, 2019 09:33 AM

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 5-YR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS